Table of Contents
ISRN Public Health
Volume 2012 (2012), Article ID 160902, 7 pages
http://dx.doi.org/10.5402/2012/160902
Research Article

The Association between Metabolic Syndrome-Related Indicators and Ten-Year Risk of Cardiovascular Disease: An Epidemiologic Assessment

1Department of Health Business Administration, Meiho University, Pingtung 91202, Taiwan
2Department of Public Health, College of Medicine, Fu Jen Catholic University, New Taipei City 24205, Taiwan
3Department of Food and Nutrition, Meiho University, Pingtung 91202, Taiwan
4Respiratory Care Center, Kaohsiung Armed Forces General Hospital, Kaohsiung City 80284, Taiwan
5Graduate Institute of Health Care, Meiho University, Pingtung 91202, Taiwan
6School of Public Health, National Defense Medical Center, Taipei City 11490, Taiwan

Received 1 September 2011; Accepted 18 October 2011

Academic Editor: K. Søgaard

Copyright © 2012 Tsan Yang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. H. Eckel, K. G. M. M. Alberti, S. M. Grundy, and P. Z. Zimmet, “The metabolic syndrome,” The Lancet, vol. 375, no. 9710, pp. 181–183, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. M. A. Cornier, D. Dabelea, T. L. Hernandez et al., “The metabolic syndrome,” Endocrine Reviews, vol. 29, no. 7, pp. 777–822, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. S. M. Grundy, “Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds,” Journal of the American College of Cardiology, vol. 47, no. 6, pp. 1093–1100, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. B. Isomaa, P. Almgren, T. Tuomi et al., “Cardiovascular morbidity and mortality associated with the metabolic syndrome,” Diabetes Care, vol. 24, no. 4, pp. 683–689, 2001. View at Google Scholar · View at Scopus
  5. J. M. Dekker, C. Girman, T. Rhodes et al., “Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study,” Circulation, vol. 112, no. 5, pp. 666–673, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Malik, N. D. Wong, S. S. Franklin et al., “Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults,” Circulation, vol. 110, no. 10, pp. 1245–1250, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. B. E. K. Klein, R. Klein, and K. E. Lee, “Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam,” Diabetes Care, vol. 25, no. 10, pp. 1790–1794, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. W. H. Pan, W. T. Yeh, and L. C. Weng, “Epidemiology of metabolic syndrome in Asia,” Asia Pacific Journal of Clinical Nutrition, vol. 17, no. 1, pp. 37–42, 2008. View at Google Scholar · View at Scopus
  9. J. I. Cleeman, “Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III),” Journal of the American Medical Association, vol. 285, no. 19, pp. 2486–2497, 2001. View at Google Scholar · View at Scopus
  10. C. E. Tan, S. Ma, D. Wai, S. K. Chew, and E. S. Tai, “Can we apply the National Cholesterol Education Program adult treatment panel definition of the metabolic syndrome to Asians?” Diabetes Care, vol. 27, no. 5, pp. 1182–1186, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. L. C. Hwang, C. H. Bai, C. J. Chen, and K. L. Chien, “Gender difference on the development of metabolic syndrome: a population-based study in Taiwan,” European Journal of Epidemiology, vol. 22, no. 12, pp. 899–906, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. A. M. J. Wassink, Y. van der Graaf, J. K. Olijhoek, and F. L. J. Visseren, “Metabolic syndrome and the risk of new vascular events and all-cause mortality in patients with coronary artery disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm,” European Heart Journal, vol. 29, no. 2, pp. 213–223, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. W. H. H. Sheu, S. Y. Chuang, W. J. Lee, S. T. Tsai, P. Chou, and C. H. Chen, “Predictors of incident diabetes, metabolic syndrome in middle-aged adults: a 10-year follow-up study from Kinmen, Taiwan,” Diabetes Research and Clinical Practice, vol. 74, no. 2, pp. 162–168, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. S. W. Lai, K. F. Liao, T. C. Li, H. F. Lin, W. Y. Lin, and C. H. Lin, “Metabolic syndrome in older people in Taiwan: a hospital-based study,” Internal Medicine Journal, vol. 36, no. 10, pp. 648–651, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. P. C.W. Van Den Hoogen, E. J.M. Feskens, N. J.D. Nagelkerke, A. Menotti, A. Nissinen, and D. Kromhout, “The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world,” New England Journal of Medicine, vol. 342, no. 1, pp. 1–8, 2000. View at Publisher · View at Google Scholar
  16. P. S. Yusuf, S. Hawken, S. Ôunpuu et al., “Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study,” Lancet, vol. 364, no. 9438, pp. 937–952, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. R. P. Wildman, D. Gu, K. Reynolds, X. Duan, X. Wu, and J. He, “Are waist circumference and body mass index independently associated with cardiovascular disease risk in Chinese adults?” American Journal of Clinical Nutrition, vol. 82, no. 6, pp. 1195–1202, 2005. View at Google Scholar · View at Scopus
  18. P. W. F. Wilson, “High-density lipoprotein, low-density lipoprotein and coronary artery disease,” American Journal of Cardiology, vol. 66, no. 6, pp. 7A–10A, 1990. View at Google Scholar · View at Scopus
  19. S. Malik, N. D. Wong, S. S. Franklin et al., “Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults,” Circulation, vol. 110, no. 10, pp. 1245–1250, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Butler, N. Rodondi, Y. Zhu et al., “Metabolic syndrome and the risk of cardiovascular disease in older adults,” Journal of the American College of Cardiology, vol. 47, no. 8, pp. 1595–1602, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. J. A. Ambrose and R. S. Barua, “The pathophysiology of cigarette smoking and cardiovascular disease: an update,” Journal of the American College of Cardiology, vol. 43, no. 10, pp. 1731–1737, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. O. Nilssen, M. Averina, T. Brenn, J. Brox, A. Kalinin, and V. Archipovski, “Alcohol consumption and its relation to risk factors for cardiovascular disease in the north-west of Russia: the Arkhangelsk study,” International Journal of Epidemiology, vol. 34, no. 4, pp. 781–788, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. P. H. Whincup, J. A. Gilg, J. R. Emberson et al., “Passive smoking and risk of coronary heart disease and stroke: prospective study with cotinine measurement,” British Medical Journal, vol. 329, no. 7459, pp. 200–204, 2004. View at Google Scholar · View at Scopus
  24. T. Y. Lan, W. C. Chang, Y. J. Tsai, Y. L. Chuang, H. S. Lin, and T. Y. Tai, “Areca nut chewing and mortality in an elderly cohort study,” American Journal of Epidemiology, vol. 165, no. 6, pp. 677–683, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. A. M. F. Yen, L. S. Chen, Y. H. Chiu, B. J. Boucher, and T. H. H. Chen, “A prospective community-population-registry-based cohort study of the association between betel-quid chewing and cardiovascular disease in men in Taiwan (KCIS no. 19),” American Journal of Clinical Nutrition, vol. 87, no. 1, pp. 70–78, 2008. View at Google Scholar · View at Scopus
  26. W. Y. Lin, T. Y. Chiu, L. T. Lee, C. C. Lin, C. Y. Huang, and K. C. Huang, “Betel nut chewing is associated with increased risk of cardiovascular disease and all-cause mortality in Taiwanese men,” American Journal of Clinical Nutrition, vol. 87, no. 5, pp. 1204–1211, 2008. View at Google Scholar · View at Scopus
  27. T. H. Tung, Y. H. Chiu, L. S. Chen, H. M. Wu, B. J. Boucher, and T. H. H. Chen, “A population-based study of the association between areca nut chewing and Type 2 diabetes mellitus in men (Keelung Community-based Integrated Screening programme No. 2),” Diabetologia, vol. 47, no. 10, pp. 1776–1781, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. W. C. Chang, C. F. Hsiao, H. Y. Chang et al., “Betel nut chewing and other risk factors associated with obesity among Taiwanese male adults,” International Journal of Obesity, vol. 30, no. 2, pp. 359–363, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. K. C. Lai and T. C. Lee, “Genetic damage in cultured human keratinocytes stressed by long-term exposure to areca nut extracts,” Mutation Research, vol. 599, no. 1-2, pp. 66–75, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. B. Molavi and J. L. Mehta, “Oxidative stress in cardiovascular disease: molecular basis of its deleterious effects, its detection, and therapeutic considerations,” Current Opinion in Cardiology, vol. 19, no. 5, pp. 488–493, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. D. Z. Hung and J. F. Deng, “Acute myocardial infarction temporally related to betel nut chewing,” Veterinary and Human Toxicology, vol. 40, no. 1, pp. 25–28, 1998. View at Google Scholar · View at Scopus
  32. J. P. Després, I. Lemieux, G. R. Dagenais, B. Cantin, and B. Lamarche, “HDL-cholesterol as a marker of coronary heart disease risk: the Québec cardiovascular study,” Atherosclerosis, vol. 153, no. 2, pp. 263–272, 2000. View at Publisher · View at Google Scholar · View at Scopus
  33. H. B. Rubins, S. J. Robins, D. Collins et al., “Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol,” New England Journal of Medicine, vol. 341, no. 6, pp. 410–418, 1999. View at Publisher · View at Google Scholar